Tag: biopsy

News

08/05/17

Needle tract seeding can result in local recurrence

11/19/10

Factors predicting upstaging from DCIS to invasive BC at biopsy

11/04/10

MRIs find additional disease in 20% of lobular BC patients

01/12/10

Risk of BC cell seeding varies according to needle biopsy method

Studies

• Pathological Underestimation of Core Needle Biopsy Risks in Ductal Carcinoma In Situ Breast Cancer Diagnosis: a Predictive Nomogram Cite
  Xie S, Wang Y, Song J, Guo J, Wang X, Cui M. Pathological Underestimation of Core Needle Biopsy Risks in Ductal Carcinoma In Situ Breast Cancer Diagnosis: a Predictive Nomogram. Research Square Platform LLC; 2024; 10.21203/rs.3.rs-4201550/v1
• Abstract 5534: Needle biopsy induces pro-metastatic progression and systemic dissemination of estrogen receptor-positive breast cancer cells through the COX-2/PGE2 cascade Cite
  Kameyama H, Leslie M, Simmons R, Sun Y, Yi M, Dondapati P, et al. Abstract 5534: Needle biopsy induces pro-metastatic progression and systemic dissemination of estrogen receptor-positive breast cancer cells through the COX-2/PGE2 cascade. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:5534-5534 10.1158/1538-7445.am2024-5534
• Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay Cite
  Kameyama H, Dondapati P, Simmons R, Leslie M, Langenheim JF, Sun Y, et al. Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay. Cell Reports Medicine. Elsevier BV; 2023; 4:101330 10.1016/j.xcrm.2023.101330
• Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare Cite
  Pathak R, Leslie M, Dondapati P, Davis R, Tanaka K, Jett E, et al. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare. Breast Cancer. Springer Science and Business Media LLC; 2023; 10.1007/s12282-023-01456-3
• Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature Cite
  Rossi C, Fraticelli S, Fanizza M, Ferrari A, Ferraris E, Messina A, et al. Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-06872-9
• Clinical significance of tumor cell seeding associated with needle biopsy in patients with breast cancer Cite
  Maseki H, Jimbo K, Watase C, Murata T, Shiino S, Takayama S, et al. Clinical significance of tumor cell seeding associated with needle biopsy in patients with breast cancer. Asian Journal of Surgery. Elsevier BV; 2023; 10.1016/j.asjsur.2023.01.026
• Inflammatory breast cancer and the importance of skin punch biopsy Cite
  Valente SA, ElSherif A, Tran J, Tu C, Kruse M. Inflammatory breast cancer and the importance of skin punch biopsy. The American Journal of Surgery. Elsevier BV; 2022; 10.1016/j.amjsurg.2022.11.017
• Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ Cite
  Pride RM, Jimenez RE, Hoskin TL, Degnim AC, Hieken TJ. Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ. Surgery. Elsevier BV; 2020; 10.1016/j.surg.2020.07.025
• Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample Cite
  Zhu S, Wu J, Huang O, He J, Zhu L, Li Y, et al. Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:2779-2786 10.1245/s10434-019-07480-y
• Does Breast Tumor Heterogeneity Necessitate Further Immunohistochemical Staining on Surgical Specimens? Cite
  Greer LT, Rosman M, Mylander WC, Hooke J, Kovatich A, Sawyer K, et al. Does Breast Tumor Heterogeneity Necessitate Further Immunohistochemical Staining on Surgical Specimens?. Journal of the American College of Surgeons. Elsevier BV; 2013; 216:239-251 10.1016/j.jamcollsurg.2012.09.007
• Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts Cite
  Román M, Hofvind S, von Euler-Chelpin M, Castells X. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts. British Journal of Cancer. Springer Science and Business Media LLC; 2018; 120:269-275 10.1038/s41416-018-0358-5
• Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics Cite
  Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, et al. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 170:129-141 10.1007/s10549-018-4735-9
• Abstract P6-03-05: Risk of needle-track seeding with serial ultrasound guided biopsies in triple negative breast cancer Cite
  Yam C, Santiago L, Candelaria R, Adrada B, Rauch G, Hess K, et al. Abstract P6-03-05: Risk of needle-track seeding with serial ultrasound guided biopsies in triple negative breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2018; 10.1158/1538-7445.sabcs17-p6-03-05
• Methylation patterns in serum DNA for early identification of disseminated breast cancer Cite
  Widschwendter M, Evans I, Jones A, Ghazali S, Reisel D, Ryan A, et al. Methylation patterns in serum DNA for early identification of disseminated breast cancer. Genome Medicine. Springer Science and Business Media LLC; 2017; 9 10.1186/s13073-017-0499-9
• Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study Cite
  Mullooly M, Khodr ZG, Dallal CM, Nyante SJ, Sherman ME, Falk R, et al. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study. American Journal of Epidemiology. Oxford University Press (OUP); 2017; 186:1329-1340 10.1093/aje/kwx206
• Core-needle biopsy of breast cancer is associated with a higher rate of distant metastases 5 to 15 years after diagnosis than FNA biopsy Cite
  Sennerstam RB, Franzén BSH, Wiksell HOT, Auer GU. Core-needle biopsy of breast cancer is associated with a higher rate of distant metastases 5 to 15 years after diagnosis than FNA biopsy. Cancer Cytopathology. Wiley; 2017; 125:748-756 10.1002/cncy.21909
• Seeding of tumour cells following breast biopsy: a literature review Cite
  Loughran CF, Keeling CR. Seeding of tumour cells following breast biopsy: a literature review. The British Journal of Radiology. British Institute of Radiology; 2011; 84:869-874 10.1259/bjr/77245199
• Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast Cite
  Santiago L, Adrada BE, Huang ML, Wei W, Candelaria RP. Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:29-39 10.1007/s10549-017-4401-7
• Recurrence of breast carcinoma as Paget disease of the skin at a prior core needle biopsy site: Case report and review of the literature Cite
  Calvillo KZ, Guo L, Brostrom V, Schnitt SJ, Hong X, Raza S, et al. Recurrence of breast carcinoma as Paget disease of the skin at a prior core needle biopsy site: Case report and review of the literature. International Journal of Surgery Case Reports. Elsevier BV; 2015; 15:152-156 10.1016/j.ijscr.2015.08.041
• Are We Overtreating Ductal Carcinoma in Situ (DCIS)? Cite
  Khan S, Epstein M, Lagios MD, Silverstein MJ. Are We Overtreating Ductal Carcinoma in Situ (DCIS)?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 24:59-63 10.1245/s10434-016-5501-z
• A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis Cite
  Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis. The Breast. Elsevier BV; 2017; 31:157-166 10.1016/j.breast.2016.11.009
• Lobular neoplasia diagnosed on breast Core biopsy: frequency of carcinoma on excision and implications for management Cite
  Calhoun BC, Collie AM, Lott-Limbach AA, Udoji EN, Sieck LR, Booth CN, et al. Lobular neoplasia diagnosed on breast Core biopsy: frequency of carcinoma on excision and implications for management. Annals of Diagnostic Pathology. Elsevier BV; 2016; 25:20-25 10.1016/j.anndiagpath.2016.07.009
• Accuracy of classification of invasive lobular carcinoma on needle core biopsy of the breast: Table 1 Cite
  Naidoo K, Beardsley B, Carder PJ, Deb R, Fish D, Girling A, et al. Accuracy of classification of invasive lobular carcinoma on needle core biopsy of the breast: Table 1. Journal of Clinical Pathology. BMJ; 2016; 69:1122-1123 10.1136/jclinpath-2016-203886
• Reliability of Prognostic and Predictive Factors Evaluated by Needle Core Biopsies of Large Breast Invasive Tumors Cite
  Petrau C, Clatot F, Cornic M, Berghian A, Veresezan L, Callonnec F, et al. Reliability of Prognostic and Predictive Factors Evaluated by Needle Core Biopsies of Large Breast Invasive Tumors. American Journal of Clinical Pathology. Oxford University Press (OUP); 2015; 144:555-562 10.1309/ajcp9kfvm2gzmndv
• Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors Cite
  Nakamura R, Yamamoto N, Shiina N, Miyaki T, Ikebe D, Itami M, et al. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors. The Breast. Elsevier BV; 2016; 26:141-147 10.1016/j.breast.2015.10.009
• Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies Cite
  Renshaw AA, Gould EW. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Pathology. Elsevier BV; 2016; 48:25-29 10.1016/j.pathol.2015.11.015
• Breast cancer prognosis and isolated tumor cell findings in axillary lymph nodes after core needle biopsy and fine needle aspiration cytology Cite
  Liikanen J, Leidenius M, Joensuu H, Vironen J, Heikkilä P, Meretoja T. Breast cancer prognosis and isolated tumor cell findings in axillary lymph nodes after core needle biopsy and fine needle aspiration cytology. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2016; 42:64-70 10.1016/j.ejso.2015.08.170
• Fine Needle Aspiration Cytology of Lobular Breast Carcinoma and Its Variants Cite
  Mucha Dufloth R, Xavier-Júnior JCC, Moraes Neto FA, Janoti dos Santos K, Schmitt F. Fine Needle Aspiration Cytology of Lobular Breast Carcinoma and Its Variants. Acta Cytologica. S. Karger AG; 2015; 59:37-42 10.1159/000370211
• Outcomes of patients with lobular in situ neoplasia of the breast: The role of vacuum-assisted biopsy Cite
  Parkin C, Garewal S, Waugh P, Maxwell A. Outcomes of patients with lobular in situ neoplasia of the breast: The role of vacuum-assisted biopsy. The Breast. Elsevier BV; 2014; 23:651-655 10.1016/j.breast.2014.06.016
• When is excision necessary for atypical lobular hyperplasia and lobular carcinoma in situ? Cite
  Rendi MH. When is excision necessary for atypical lobular hyperplasia and lobular carcinoma in situ?. Breast Cancer Management. Future Medicine Ltd; 2014; 3:145-153 10.2217/bmt.13.78
• The sensitivity of pre-operative axillary staging in breast cancer: Comparison of invasive lobular and ductal carcinoma Cite
  Topps A, Clay V, Absar M, Howe M, Lim Y, Johnson R, et al. The sensitivity of pre-operative axillary staging in breast cancer: Comparison of invasive lobular and ductal carcinoma. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2014; 40:813-817 10.1016/j.ejso.2014.03.026
• Upper Limb Physical Function and Adverse Effects After Breast Cancer Surgery: A Prospective 2.5-Year Follow-Up Study and Preoperative Measures Cite
  Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA. Upper Limb Physical Function and Adverse Effects After Breast Cancer Surgery: A Prospective 2.5-Year Follow-Up Study and Preoperative Measures. Archives of Physical Medicine and Rehabilitation. Elsevier BV; 2014; 95:875-881 10.1016/j.apmr.2013.12.015
• Core Needle Biopsy of Breast Cancer Tumors Increases Distant Metastases in a Mouse Model Cite
  Mathenge EG, Dean CA, Clements D, Vaghar-Kashani A, Photopoulos S, Coyle KM, et al. Core Needle Biopsy of Breast Cancer Tumors Increases Distant Metastases in a Mouse Model. Neoplasia. Elsevier BV; 2014; 16:950-960 10.1016/j.neo.2014.09.004
• Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient Cite
  Hoefnagel L, van der Groep P, van de Vijver M, Boers J, Wesseling P, Wesseling J, et al. Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient. Annals of Oncology. Elsevier BV; 2013; 24:3017-3023 10.1093/annonc/mdt390
• Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis Cite
  Curtit E, Nerich V, Mansi L, Chaigneau L, Cals L, Villanueva C, et al. Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis. The Oncologist. Wiley; 2013; 18:667-674 10.1634/theoncologist.2012-0350
• Long-Term Follow-up of Lobular Neoplasia (Atypical Lobular Hyperplasia/Lobular Carcinoma In Situ) Diagnosed on Core Needle Biopsy Cite
  Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, DePeri ER, Glazebrook KN. Long-Term Follow-up of Lobular Neoplasia (Atypical Lobular Hyperplasia/Lobular Carcinoma In Situ) Diagnosed on Core Needle Biopsy. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 19:3131-3138 10.1245/s10434-012-2534-9
• The Significance of Lobular Carcinoma In Situ and Atypical Lobular Hyperplasia of the Breast Cite
  Lewis JL, Lee DY, Tartter PI. The Significance of Lobular Carcinoma In Situ and Atypical Lobular Hyperplasia of the Breast. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 19:4124-4128 10.1245/s10434-012-2538-5
• Malignant Seeding Following Percutaneous Breast Biopsy: Documentation With Comprehensive Imaging and Clinical Implications Cite
  Brenner RJ, Gordon LM. Malignant Seeding Following Percutaneous Breast Biopsy: Documentation With Comprehensive Imaging and Clinical Implications. The Breast Journal. Wiley; 2011; 17:651-656 10.1111/j.1524-4741.2011.01156.x
• Association of core needle biopsies with increase in metastatic dissemination of breast cancer. Cite
  Giacomantonio CA, Dean CA, Mathenge EG, Black AA, Schulte W, Pink DB, et al. Association of core needle biopsies with increase in metastatic dissemination of breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:e21090-e21090 10.1200/jco.2012.30.15_suppl.e21090
• Management of Patients Diagnosed With Lobular Carcinoma in Situ at Needle Core Biopsy at a Community-Based Outpatient Facility Cite
  Destounis SV, Murphy PF, Seifert PJ, Somerville PA, Arieno AL, Morgan RC, et al. Management of Patients Diagnosed With Lobular Carcinoma in Situ at Needle Core Biopsy at a Community-Based Outpatient Facility. American Journal of Roentgenology. American Roentgen Ray Society; 2012; 198:281-287 10.2214/ajr.11.7043
• Nonsurgical Management of High-Risk Lesions Diagnosed at Core Needle Biopsy: Can Malignancy Be Ruled Out Safely With Breast MRI? Cite
  Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, et al. Nonsurgical Management of High-Risk Lesions Diagnosed at Core Needle Biopsy: Can Malignancy Be Ruled Out Safely With Breast MRI?. American Journal of Roentgenology. American Roentgen Ray Society; 2012; 198:272-280 10.2214/ajr.11.7040
• Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses Cite
  Rakha EA, Lee AH, Reed J, Murphy A, El-Sayed M, Burrell H, et al. Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. European Journal of Cancer. Elsevier BV; 2010; 46:1835-1840 10.1016/j.ejca.2010.03.024
• The Diagnosis of Pleomorphic Lobular Carcinoma In Situ Warrants Complete Excision with Negative Margins Cite
  Middleton LP. The Diagnosis of Pleomorphic Lobular Carcinoma In Situ Warrants Complete Excision with Negative Margins. Current Breast Cancer Reports. Springer Science and Business Media LLC; 2012; 4:96-101 10.1007/s12609-012-0072-x
• Low Frequency of Cancer Occurrence in Same Breast Quadrant Diagnosed with Lobular Neoplasia at Percutaneous Needle Biopsy Cite
  Provencher L, Jacob S, Côté G, Hogue J, Desbiens C, Poirier B, et al. Low Frequency of Cancer Occurrence in Same Breast Quadrant Diagnosed with Lobular Neoplasia at Percutaneous Needle Biopsy. Radiology. Radiological Society of North America (RSNA); 2012; 263:43-52 10.1148/radiol.11111293
• Lobular neoplasia on core biopsy: Is excision always indicated? Cite
  Makarewich CA, Rosenkranz KM. Lobular neoplasia on core biopsy: Is excision always indicated?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:75-75 10.1200/jco.2011.29.27_suppl.75
• Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast–A review Cite
  Hussain M, Cunnick G. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast–A review. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:279-289 10.1016/j.ejso.2011.01.009
• A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression Cite
  Ough M, Velasco J, Hieken TJ. A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression. The American Journal of Surgery. Elsevier BV; 2011; 201:692-694 10.1016/j.amjsurg.2010.02.015
• Risk Factors for Invasive Breast Cancer When Core Needle Biopsy Shows Ductal Carcinoma In Situ Cite
  Kurniawan ED. Risk Factors for Invasive Breast Cancer When Core Needle Biopsy Shows Ductal Carcinoma In Situ. Archives of Surgery. American Medical Association (AMA); 2010; 145:1098 10.1001/archsurg.2010.243
• Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit Cite
  Cain H, Sinclair J, Martin A, Fasih T, Browell D, Clark K, et al. Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit. Breast Cancer Research. Springer Science and Business Media LLC; 2010; 12 10.1186/bcr2680
• Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases Cite
  de Boer M, van Dijck JAAM, Bult P, Borm GF, Tjan-Heijnen VCG. Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:410-425 10.1093/jnci/djq008
• Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes Cite
  Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:170-178 10.1093/jnci/djp482
• Local breast cancer recurrence caused by mammographically guided punctures Cite
  Thurfjell M, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E. Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiologica. SAGE Publications; 2000; 41:435-440 10.1080/028418500127345884
• Preoperative Core Needle Biopsy does not Increase Local Recurrence Rate in Breast Cancer Patients Cite
  Fitzal F, Sporn EP, Draxler W, Mittlböck M, Taucher S, Rudas M, et al. Preoperative Core Needle Biopsy does not Increase Local Recurrence Rate in Breast Cancer Patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2006; 97:9-15 10.1007/s10549-005-6935-3
• A prospective study of seeding of the skin after core biopsy of the breast Cite
  Stolier A, Skinner J, Levine EA. A prospective study of seeding of the skin after core biopsy of the breast. The American Journal of Surgery. Elsevier BV; 2000; 180:104-107 10.1016/s0002-9610(00)00425-6
• Tumour cell displacement after 14G breast biopsy Cite
  Hoorntje L, Schipper M, Kaya A, Verkooijen H, Klinkenbijl J, Rinkes I. Tumour cell displacement after 14G breast biopsy. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2004; 30:520-525 10.1016/j.ejso.2004.03.001
• Breast cancer seeding associated with core needle biopsies: A systematic review Cite
  Liebens F, Carly B, Cusumano P, Van Beveren M, Beier B, Fastrez M, et al. Breast cancer seeding associated with core needle biopsies: A systematic review. Maturitas. Elsevier BV; 2009; 62:113-123 10.1016/j.maturitas.2008.12.002
• The use of positive core wash cytology to estimate potential risk of needle tract seeding of breast cancer: directional vacuum-assisted biopsy versus automated core needle biopsy Cite
  Uematsu T, Kasami M. The use of positive core wash cytology to estimate potential risk of needle tract seeding of breast cancer: directional vacuum-assisted biopsy versus automated core needle biopsy. Breast Cancer. Springer Science and Business Media LLC; 2009; 17:61-67 10.1007/s12282-009-0109-9
• Risk of needle tract seeding of breast cancer: cytological results derived from core wash material Cite
  Uematsu T, Kasami M. Risk of needle tract seeding of breast cancer: cytological results derived from core wash material. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2007; 110:51-55 10.1007/s10549-007-9685-6
• Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy Cite
  Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, et al. Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy. Journal of the American College of Surgeons. Elsevier BV; 2009; 209:746-752 10.1016/j.jamcollsurg.2009.08.010
• Axillary Sentinel Lymph Nodes Can Be Falsely Positive Due to Iatrogenic Displacement and Transport of Benign Epithelial Cells in Patients With Breast Carcinoma Cite
  Bleiweiss IJ, Nagi CS, Jaffer S. Axillary Sentinel Lymph Nodes Can Be Falsely Positive Due to Iatrogenic Displacement and Transport of Benign Epithelial Cells in Patients With Breast Carcinoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2006; 24:2013-2018 10.1200/jco.2005.04.7076